Clinical trial Recruiting at 1 site Interventional Ages 18 to 40

How 24-hour sleep loss affects people with different APOE genes

Official title: Effects of Acute Sleep Deprivation on Individuals With Different APOE Genotypes

Run by Guangdong Provincial Hospital of Traditional Chinese Medicine · NCT07085754 · Data updated 2026-11-12

This will see if 24 hours without sleep changes blood Alzheimer's-related markers in healthy adults with different APOE gene types.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexAll
Enrollment60 (estimated)
SponsorGuangdong Provincial Hospital of Traditional Chinese Medicine
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedAugust 8, 2025
Main results expectedDecember 31, 2025
Study endsDecember 31, 2026
Registry record updatedDecember 24, 2025
Trial IDNCT07085754 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults 18–40 years old who normally sleep 7–9 hours per night, are cognitively normal, not taking regular medications, and willing to undergo a 24-hour overnight visit and blood draws are ideal candidates.

Probably not a fit

People with cognitive impairment, older adults, recent shift workers or travelers, current smokers, heavy drinkers, or those on regular medications are unlikely to be eligible or to benefit from this specific protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will enroll 60 healthy adults aged 18–40 and stratify them by APOE genotype (ε3/3, ε4 carriers, and ε2 carriers). Within each genotype stratum participants will be randomly assigned to either 24 hours of acute sleep deprivation or to normal sleep. Blood samples will be collected before and after the intervention to measure plasma Aβ42 and a range of multi-omics biomarkers, with the primary outcome being the change in plasma Aβ42 the day after randomization. The design tests whether a single night of sleep loss produces different molecular responses depending on APOE genotype.

Why it matters

Potential benefit: If successful, the results could help identify how brief sleep loss affects Alzheimer's-related blood markers by genetic risk and inform targeted prevention or monitoring strategies.

How similar studies have gone: Prior short-term sleep deprivation studies have reported changes in CSF and blood Aβ and tau, but combining stratified APOE genotyping with multi-omics profiling is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-40 years, gender not limited
* Healthy (with no clinically significant abnormal findings in the physical examination report or self-reporting as healthy) and not on medications
* Cognitively normal (Mini-Mental State Examination (MMSE) score \> 28)
* Sleep duration of 7-9 hours per night, good sleep quality (Pittsburgh Sleep Quality Index (PSQI) ≤ 5 points)
* Written informed consent, voluntarily participate in this study, and be able to cooperate with the physician to complete the clinical study

Exclusion Criteria:

* Presence of day-night sleep reversal
* Shift work within the past 6 months
* Travel across time zones or experience of jet lag within the past three weeks
* Current smoking or nicotine use; alcohol consumption exceeding five standard units per week (one standard alcohol unit is defined as 10 mL \[or 8 g\] of pure alcohol)
* Consumption of strong tea, coffee, or caffeine-containing foods and beverages within one week before study participation
* Family history of early-onset dementia
* Self-Rating Depression Scale (SDS) score ≥ 53, Self-Rating Anxiety Scale (SAS) score ≥ 50
* Female participants who are currently pregnant or breastfeeding
* Individuals who need to drive or operate vehicles or machinery during the study period

Where it's running

  • Guangdong Provincial Hospital of Chinese Medicine
    Guangzhou, Guangdong, China
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.